Login / Signup

Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model.

Annalaura BraiFederica PoggialiniChiara VagagginiClaudia PasqualiniSauro SimoniValeria FrancardiElena Dreassi
Published in: International journal of molecular sciences (2023)
The progression of drugs into clinical phases requires proper toxicity assessment in animals and the correct identification of possible metabolites. Accordingly, different animal models are used to preliminarily evaluate toxicity and biotransformations. Rodents are the most common models used to preliminarily evaluate the safety of drugs; however, their use is subject to ethical consideration and elevated costs, and strictly regulated by national legislations. Herein, we developed a novel, cheap and convenient toxicity model using Tenebrio molitor coleoptera (TMC). A panel of 15 drugs-including antivirals and antibacterials-with different therapeutic applications was administered to TMC and the LD50 was determined. The values are comparable with those already determined in mice and rats. In addition, a TMC model was used to determine the presence of the main metabolites and in vivo pharmacokinetics (PK), and results were compared with those available from in vitro assays and the literature. Taken together, our results demonstrate that TMC can be used as a novel and convenient preliminary toxicity model to preliminarily evaluate the safety of experimental compounds and the formation of main metabolites, and to reduce the costs and number of rodents, according to 3R principles.
Keyphrases
  • oxidative stress
  • ms ms
  • type diabetes
  • metabolic syndrome
  • high throughput
  • bone marrow
  • quality improvement